Case report
Open access
Oct 2026
Inflammatory rheumatic diseases under mogamulizumab: a multicenter series of 11 cases.
BACKGROUND Mogamulizumab (MOGA), an anti-CCR4 monoclonal antibody for mycosis fungoides (MF) and Sézary syndrome (SS), can trigger immune-mediated complications, such as rashes or endocrine disorders. Rheumatological manifestations are rare. OBJECTIVES To describe cases of inflammatory rheumatism (IR) induced or wors...
Arno Wahler, S. Guignard, G. Quereux et al.
· Joint Bone Spine · 0 citations